May 13 (Reuters) - Johnson & Johnson will sell all its 182.3 million shares in its spun-off company Kenvue in a stock offering in a debt-for-equity exchange, the consumer health product firm said in a filing on Monday. (Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.44 USD | -2.21% | -5.66% | -9.73% |
05-22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
05-20 | Goldman Sachs Adjusts Kenvue Price Target to $21 From $20 | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
149.7 USD | -2.48% | -2.99% | 369B | ||
19.44 USD | -2.21% | -5.66% | 38.07B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.73% | 38.07B | |
+12.88% | 396B | |
+13.47% | 136B | |
+17.53% | 77.74B | |
-10.61% | 66.79B | |
-13.77% | 46.89B | |
+7.81% | 35.65B | |
+10.88% | 18.19B | |
+16.69% | 16.04B | |
+0.49% | 11.79B |
- Stock Market
- Equities
- KVUE Stock
- News Kenvue Inc.
- J&J to sell all shares in spun-off unit Kenvue